Have additional questions?
Connect with CSL Behring Medical Affairs to find additional information and ask questions.
950,000+ patient-years of therapy in 14+ years of clinical use1
Annual rate of serious bacterial infections* in the extension study was 0.0214
97% of adverse reactions were non-serious in the pivotal trial†, and 96% were non-serious in the extension trial‡14
In the clinical studies, the most common adverse reactions, observed in >5% of study subjects, were headache, fatigue, nausea, chills, vomiting, back pain, pain, elevated body temperature, abdominal pain, diarrhea, cough, stomach discomfort, chest pain, joint swelling/effusion, influenza-like illness, pharyngolaryngeal pain, urticaria, and dizziness.
Connect with CSL Behring Medical Affairs to find additional information and ask questions.
Overall response rates to Privigen were 61% and 73% in PRIMA and PATH,* respectively†
Almost all who responded† to Privigen did so after 1–2 maintenance treatments at Weeks 4 and 7*
In both studies,* 97% of adverse reactions were mild or moderate in intensity with 2 and 8 subjects experiencing serious adverse reactions in PRIMA and PATH, respectively‡
PATH, one of two clinical trials,* was the largest ever CIDP study, evaluating 207 patients
In the clinical studies, the most common reactions, observed in >5% of subjects, were headache, asthenia, hypertension, nausea, pain in extremity, hemolysis, influenza-like illness, leukopenia, and rash.
In PRIMA:
In PATH:
Connect with CSL Behring Medical Affairs to find additional information and ask questions.
80.7% had a 150% platelet count increase within 7 days*12
Mean platelet count rose above 50 x 109/L in 1 day*12
Duration of response was at least 8.8 days in 75% of patients*12
* Study was performed on 57 subjects with chronic ITP. Each subject had a platelet count of ≤20 x 109/L. Dose was 1 g/kg on 2 consecutive days. Primary endpoint was elevation of platelet count to at least 50 x 109/L within 7 days of infusion.
Connect with CSL Behring Medical Affairs to find additional information and ask questions.
Use the guide or dosing calculator to determine the right amount of Privigen for your patients
Find out what proline is and why it's in Privigen